Premature Enhanced Automated Capture of Comfort Knowledge
Launched by NEWCASTLE UNIVERSITY · Sep 7, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying ways to better monitor the comfort levels of preterm infants in hospitals. The goal is to find methods that can help healthcare providers understand how these babies are feeling, especially when they are experiencing pain or discomfort. By keeping track of their comfort continuously, the hope is to improve their care and overall experience in the hospital.
To be eligible for this study, infants must be born before 36 weeks of pregnancy and be medically stable, meaning they are not facing serious health issues. Parents will need to give their written consent for their child to participate. Unfortunately, infants with major brain or spine problems, or those whose parents do not wish to participate, will not be included in the study. If you decide to participate, you can expect regular comfort assessments that will help doctors and nurses provide the best possible care for your baby during their time in the hospital.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Preterm Infants born \<36 completed weeks of gestation
- • Medically stable
- • Written informed consent from parents
- Exclusion Criteria:
- • Infants with significant brain, spine, or congenital abnormality
- • Parents unwilling to provide consent
- • Infants with postmenstrual age \>36 weeks
About Newcastle University
Newcastle University is a leading research institution located in the United Kingdom, renowned for its commitment to advancing healthcare through innovative clinical trials and scientific research. The university's Clinical Trials Unit plays a pivotal role in the design, coordination, and execution of high-quality clinical studies, focusing on a wide range of therapeutic areas. With a multidisciplinary team of experts, Newcastle University fosters collaboration between academia, industry, and healthcare providers, ensuring that research findings translate into meaningful advancements in patient care. Its dedication to excellence and ethical standards positions Newcastle University as a trusted sponsor in the clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Newcastle Upon Tyne, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported